These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38956085)

  • 21. Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.
    Karampampa K; Gustavsson A; Miltenburger C; Kindundu CM; Selchen DH
    J Popul Ther Clin Pharmacol; 2012; 19(1):e11-25. PubMed ID: 22247419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COPD symptom burden: impact on health care resource utilization, and work and activity impairment.
    Ding B; Small M; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():677-689. PubMed ID: 28260874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China.
    Guojun T; Yan X; Weizhi W; Lihua W; Chunyang L; Xinghu Z; Hongyu Z; Huiqing D; Meini Z; Tao J; Huan Y; Liying C; Li G
    Mult Scler Relat Disord; 2022 Apr; 60():103732. PubMed ID: 35325723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.
    Ritchie CW; Khandker RK; Pike J; Black CM; Jones E; Ambegaonkar BM
    J Alzheimers Dis; 2018; 64(3):899-910. PubMed ID: 29966202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct and indirect economic consequences of multiple sclerosis in Ireland.
    Fogarty E; Walsh C; McGuigan C; Tubridy N; Barry M
    Appl Health Econ Health Policy; 2014 Dec; 12(6):635-45. PubMed ID: 25227118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group.
    Can J Neurol Sci; 1998 Feb; 25(1):23-30. PubMed ID: 9532277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost of multiple sclerosis in Australia.
    Taylor B; McDonald E; Fantino B; Sedal L; MacDonnell R; Pittas F; Groom T; Beresniak A
    J Clin Neurosci; 2007 Jun; 14(6):532-9. PubMed ID: 17430777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic burden of multiple sclerosis in the United States: A systematic literature review.
    Schauf M; Chinthapatla H; Dimri S; Li E; Hartung DM
    J Manag Care Spec Pharm; 2023 Dec; 29(12):1354-1368. PubMed ID: 37976077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G
    Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
    Chuvarayan Y; Finger RP; Köberlein-Neu J
    Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality-of-life, work productivity, and economic burden among patients with Parkinson's disease in Japan.
    Yamabe K; Liebert R; Flores N; Pashos C
    J Med Econ; 2018 Dec; 21(12):1206-1212. PubMed ID: 30200795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes.
    Pawaskar M; Iglay K; Witt EA; Engel SS; Rajpathak S
    J Diabetes Complications; 2018 May; 32(5):451-457. PubMed ID: 29496365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
    Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The societal costs of multiple sclerosis in Lebanon: a cross-sectional study.
    Dahham J; Hiligsmann M; Kremer I; Khoury SJ; Darwish H; Hosseini H; Evers S; Rizk R
    Expert Rev Pharmacoecon Outcomes Res; 2023 Apr; 23(4):419-430. PubMed ID: 36820619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
    Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
    Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic Burden of Illness in Adult Patients with Nocturia.
    Dmochowski R; Brucker BM; Cole E; Kawahara S; Pulicharam R; Burk C; Tung A; Hale D
    J Manag Care Spec Pharm; 2019 May; 25(5):593-604. PubMed ID: 30675816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.
    Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M
    BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression.
    Brown LJ; Li J; Brunner M; Snoke M; La HA
    J Med Econ; 2021; 24(1):140-149. PubMed ID: 33461357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy.
    Amato MP; Battaglia MA; Caputo D; Fattore G; Gerzeli S; Pitaro M; Reggio A; Trojano M;
    J Neurol; 2002 Feb; 249(2):152-63. PubMed ID: 11985380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.